<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02515825</url>
  </required_header>
  <id_info>
    <org_study_id>1217-001</org_study_id>
    <nct_id>NCT02515825</nct_id>
  </id_info>
  <brief_title>Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)</brief_title>
  <acronym>AMBIENCE</acronym>
  <official_title>Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AUM Cardiovascular, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AUM Cardiovascular, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center study to capture information on sensitivity and&#xD;
      specificity of CADence using coronary angiogram as the gold standard, on subjects who are&#xD;
      already scheduled for coronary angiography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CADence is an ECG and acoustic tool to assess coronary artery disease. This study's goal is&#xD;
      to collect patient CADence information and compare it to the results of angiogram to&#xD;
      determine performance: sensitivity and specificity. The CADence is not used to direct patient&#xD;
      care. This is observational only.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of Participants With Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as Accurate and Appropriate</measure>
    <time_frame>24 hours or discharge from hospital, whichever is sooner</time_frame>
    <description>Angiographically significant stenosis was defined as 70% or greater stenosis in any major coronary artery. Percent of Participants with Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as accurate and appropriate. The study is used to determine two conditions. CADence = Positive for 70% or greater stenosis and CADence = Negative for less than 70% stenosis. The pre-specified intent of this Outcome Measure was to assess all study participants combined, irrespective of whether or not they participated in the Ambience main study or the repeatability and reproducibility sub-study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With CADence-related Adverse Events</measure>
    <time_frame>24 hours or discharge from hospital, whichever is sooner</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">101</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>AMBIENCE</arm_group_label>
    <description>CADence System testing followed by coronary angiogram</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AMBIENCE plus R&amp;R Substudy</arm_group_label>
    <description>CADence System testing for repeatibility and reproducibility (4x by 2 operators) followed by coronary angiogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CADence</intervention_name>
    <arm_group_label>AMBIENCE</arm_group_label>
    <arm_group_label>AMBIENCE plus R&amp;R Substudy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects already scheduled for coronary angiography who meet study inclusion and exclusion&#xD;
        criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;40 years&#xD;
&#xD;
          -  Clinical indication for coronary angiogram&#xD;
&#xD;
          -  Willing and able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body Mass Index (BMI) &lt;18.5 or &gt;40&#xD;
&#xD;
          -  Prior bypass surgery or coronary stenting&#xD;
&#xD;
          -  Presence of pacemaker/defibrillator&#xD;
&#xD;
          -  Presence of artificial valve&#xD;
&#xD;
          -  Presence of obvious cyanotic or pre-diagnosed congenital heart defect and coarctation&#xD;
             of the aorta&#xD;
&#xD;
          -  Presence of murmurs, including valve lesions, ventricular septal defects and&#xD;
             arteriovenous fistulae&#xD;
&#xD;
          -  Presence of moderate-severe valve disease&#xD;
&#xD;
          -  Left Ventricular Assist Device (LVAD)&#xD;
&#xD;
          -  Presence of scars on the site thorax areas&#xD;
&#xD;
          -  Participation in trial within 30 days prior to collecting CADence data except&#xD;
             participation in registry studies.&#xD;
&#xD;
          -  Asthma or chronic obstructive pulmonary disease (COPD) with active wheezing&#xD;
&#xD;
          -  Inability to lie in supine position&#xD;
&#xD;
          -  Heart Transplant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>41 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmelo Panetta, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Center Research, LLC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2015</study_first_posted>
  <results_first_submitted>January 8, 2018</results_first_submitted>
  <results_first_submitted_qc>March 9, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 15, 2021</results_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will not be shared</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects &gt;40 years of age and scheduled for clinically-indicated angiography were recruited at 3 hospitals across the US.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>AMBIENCE Study</title>
          <description>Participants in the initial AMBIENCE study period</description>
        </group>
        <group group_id="P2">
          <title>AMBIENCE Plus R &amp; R</title>
          <description>Participants in the AMBIENCE plus Repeatability and Reproducibility portion of the study</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>AMBIENCE</title>
          <description>CADence System testing followed by coronary angiogram&#xD;
CADence System: Obtain CADence data under normal conditions of use for comparison of results with those of coronary angiogram</description>
        </group>
        <group group_id="B2">
          <title>AMBIENCE Plus R&amp;R Substudy</title>
          <description>CADence System testing for repeatability and reproducibility (4x by 2 operators) followed by coronary angiogram&#xD;
CADence System: Obtain CADence data under normal conditions for comparison of results with those of coronary angiogram.&#xD;
This part of the study includes patients who are a part of the AMBIENCE study.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="70"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="101"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.14" spread="8.82"/>
                    <measurement group_id="B2" value="64.65" spread="11.14"/>
                    <measurement group_id="B3" value="63.60" spread="9.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race/Ethnicity</title>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent of Participants With Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as Accurate and Appropriate</title>
        <description>Angiographically significant stenosis was defined as 70% or greater stenosis in any major coronary artery. Percent of Participants with Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as accurate and appropriate. The study is used to determine two conditions. CADence = Positive for 70% or greater stenosis and CADence = Negative for less than 70% stenosis. The pre-specified intent of this Outcome Measure was to assess all study participants combined, irrespective of whether or not they participated in the Ambience main study or the repeatability and reproducibility sub-study.</description>
        <time_frame>24 hours or discharge from hospital, whichever is sooner</time_frame>
        <population>The Ambience study included a sub-study within the same population. The sub-study was to evaluate the repeatability and reproducibility of the CADence System. Repeatability refers to the ability of the same System operator to obtain the same results each time the same subject is tested with the same System at two points in time. Reproducibility refers to the ability of different operators to obtain the same results when they evaluate the same subjects with either the same or different Systems.</population>
        <group_list>
          <group group_id="O1">
            <title>Patient CADence Result</title>
            <description>CADence System testing followed by coronary angiogram&#xD;
CADence System: Obtain CADence data under normal conditions of use for comparison of results with those of coronary angiogram</description>
          </group>
          <group group_id="O2">
            <title>Repeatability and Reproducibility</title>
            <description>The purpose of the study is to collect performance information regarding the use of the CADence system under normal conditions of use. Includes a 31-subject sub-study to assess the repeatability and reproducibility of the CADence system</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Participants With Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as Accurate and Appropriate</title>
          <description>Angiographically significant stenosis was defined as 70% or greater stenosis in any major coronary artery. Percent of Participants with Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as accurate and appropriate. The study is used to determine two conditions. CADence = Positive for 70% or greater stenosis and CADence = Negative for less than 70% stenosis. The pre-specified intent of this Outcome Measure was to assess all study participants combined, irrespective of whether or not they participated in the Ambience main study or the repeatability and reproducibility sub-study.</description>
          <population>The Ambience study included a sub-study within the same population. The sub-study was to evaluate the repeatability and reproducibility of the CADence System. Repeatability refers to the ability of the same System operator to obtain the same results each time the same subject is tested with the same System at two points in time. Reproducibility refers to the ability of different operators to obtain the same results when they evaluate the same subjects with either the same or different Systems.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With CADence-related Adverse Events</title>
        <time_frame>24 hours or discharge from hospital, whichever is sooner</time_frame>
        <population>All participants were assessed and none had adverse events</population>
        <group_list>
          <group group_id="O1">
            <title>Adverse Events</title>
            <description>There were zero reported adverse events.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With CADence-related Adverse Events</title>
          <population>All participants were assessed and none had adverse events</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Adverse Events</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No adverse events</title>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event information was only collected through study exit for each subject (1 day).</time_frame>
      <desc>All Adverse Events (AEs) and Serious Adverse Events (SAEs) associated with CADence use through discharge were recorded. Those associated with the coronary angiogram and/or subsequent interventions were not collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>AMBIENCE</title>
          <description>CADence System testing followed by coronary angiogram&#xD;
CADence System: Obtain CADence data under normal conditions of use for comparison of results with those of coronary angiogram</description>
        </group>
        <group group_id="E2">
          <title>AMBIENCE Plus R&amp;R Substudy</title>
          <description>CADence System testing for repeatibility and reproducibility (4x by 2 operators) followed by coronary angiogram&#xD;
CADence System: Obtain CADence data under normal conditions of use for comparison of results with those of coronary angiogram</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Marie Johnson, PhD</name_or_title>
      <organization>AUM Cardiovascular</organization>
      <phone>612.799.2511</phone>
      <email>mariej@aumcv.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

